The fourth quarter closed out a successful year for the Madison Small Cap Fund, delivering solid absolute and relative ...

BMO Capital analyst John McNulty raised the firm’s price target on Ingevity (NGVT) to $62 from $61 and keeps a Market Perform rating on the ...

BMO Capital lowered the firm’s price target on Ionis Pharmaceuticals (IONS) to $45 from $60 and keeps a Market Perform rating on the shares.

DTE Energy (NYSE:DTE – Get Free Report) had its price target boosted by investment analysts at BMO Capital Markets from ...

Ameren (NYSE:AEE – Get Free Report) had its target price lifted by research analysts at BMO Capital Markets from $100.00 to ...